Isolation of anti-SARS Co-V-2 broadly neutralizing antibodies

We analyze COVID-19 convalescent donors in the search for antibodies that will inhibit the virus and serve as guides for vaccine development.

Interdisciplinary basic and translational research

We combine molecular immunology with genetics, protein engineering and data analysis to understand how our immune system reacts to diseases, and develop new antibody-based drugs and vaccines.

Isolation of anti-Tuberculosis antibodies

Recent studies suggest that antibodies have function during Tuberculosis infection and disease. Our goal is to isolate and characterize anti-Tuberculosis neutralizing antibodies and use them as potential drugs, diagnostics and guides for vaccines